Karyopharm Therapeutics Inc. amends IPO

Karyopharm Therapeutics Inc., Natick, Mass. Business: Cancer, Inflammation Date announced: 10/28/13 Type: IPO To be raised: Up to $90.7 million Shares: 5.7 million Price: $14-$16 Underwriters: BofA Me...